After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
LYEL belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Lyell Immunopharma Inc is $129.63M. A total of 0.68 million shares were traded on the day, compared to an average of 1.00M shares.
In the most recent transaction, BRAWLEY OTIS W bought 35,640 shares of LYEL for 0.56 per share on Mar 31 ’25. After the transaction, the Director now owns 35,640 company shares. In a previous transaction on Mar 21 ’25, Ramachandra Sumant bought 200,000 shares at 0.58 per share. LYEL shares that Director owns now total 200,000.
Among the insiders who bought shares, Klausner Richard acquired of 158,000 shares on Mar 14 ’25 at a per-share price of $0.60. This resulted in the Director holding 843,365 shares of LYEL after the transaction. In another insider transaction, Newton Charles W. bought 200,000 shares at $0.56 per share on Mar 17 ’25. Company shares held by the Chief Financial Officer now total 200,000.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, LYEL has a high of $2.88 and a low of $0.39.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. LYEL’s latest balance sheet shows that the firm has $614.79M in Cash & Short Term Investments as of fiscal 2021. There were $67.82M in debt and $46.74M in liabilities at the time. Its Book Value Per Share was $1.30, while its Total Shareholder’s Equity was $929.79M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LYEL is Buy with a score of 2.75.
